Journal Home
Search for

Volume 6, Issue 1, Pages 110-122 (January 2010)


View previous. 15 of 38 View next.

A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts

Lorenzo Solettiabcd, Yi Hongbcd, Jianjun Guanbcd, John J. Stankusce, Mohammed S. El-Kurdiabcd, William R. Wagnerabcde, David A. VorpabcdCorresponding Author Informationemail address

Received 18 February 2009; received in revised form 14 May 2009; accepted 11 June 2009. published online 19 June 2009.

Abstract 

A major barrier to the development of a clinically useful small diameter tissue engineered vascular graft (TEVG) is the scaffold component. Scaffold requirements include matching the mechanical and structural properties with those of native vessels and optimizing the microenvironment to foster cell integration, adhesion and growth. We have developed a small diameter, bilayered, biodegradable, elastomeric scaffold based on a synthetic, biodegradable elastomer. The scaffold incorporates a highly porous inner layer, allowing cell integration and growth, and an external, fibrous reinforcing layer deposited by electrospinning. Scaffold morphology and mechanical properties were assessed, quantified and compared with those of native vessels. Scaffolds were then seeded with adult stem cells using a rotational vacuum seeding device to obtain a TEVG, cultured under dynamic conditions for 7days and evaluated for cellularity. The scaffold showed firm integration of the two polymeric layers with no delamination. Mechanical properties were physiologically consistent, showing anisotropy, an elastic modulus (1.4±0.4MPa) and an ultimate tensile stress (8.3±1.7MPa) comparable with native vessels. The compliance and suture retention forces were 4.6±0.5×10−4mmHg−1 and 3.4±0.3N, respectively. Seeding resulted in a rapid, uniform, bulk integration of cells, with a seeding efficiency of 92±1%. The scaffolds maintained a high level of cellular density throughout dynamic culture. This approach, combining artery-like mechanical properties and a rapid and efficient cellularization, might contribute to the future clinical translation of TEVGs.

a Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA

b Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15219, USA

c McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA

d Center for Vascular Remodeling and Regeneration, University of Pittsburgh, Pittsburgh, PA 15219, USA

e Department of Chemical Engineering, University of Pittsburgh, Pittsburgh, PA 15219, USA

Corresponding Author InformationCorresponding author. Address: Department of Bioengineering, University of Pittsburgh, 100 Technology Drive, Suite 200, Pittsburgh, PA 15219, USA. Tel.: +1 412 235 5136; fax: +1 412 235 5110.

PII: S1742-7061(09)00278-5

doi:10.1016/j.actbio.2009.06.026


View previous. 15 of 38 View next.